Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clozapine-resistant schizophrenia polypharmacy study
2009-011307-22Phase 4Completed
- Sponsor
- Niuvanniemi Hospital
- Start
- Mar 2009
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in schizophrenia comparing Clozapine monotherapy with Clozapine + olanzapine (2 arms). Primary endpoints: Global Assessment of Functioning (GAF) score and Modified Clinical Global Impression of Severity (CGI-S). Started Mar 2009; status: completed.
02
Drugs
clozapineolanzapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2009-011307-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011307-22.